Review: Reactive oxygen and nitrogen species and functional adaptation of the placenta

Placenta

Volumn 31, Issue SUPPL., 2010, Pages

  Myatt, L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Nitrative stress; Nitric oxide; Oxidative stress; Placenta; Superoxide

Indexed keywords

3 NITROTYROSINE; ACYLTRANSFERASE; ARGININE; COENZYME A ACYLTRANSFERASE; GLUCOSE TRANSPORTER 1; LYSINE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PEPTIDE HORMONE; PEROXYNITRITE; PROLINE; PROTEIN P53; PURINERGIC P2X4 RECEPTOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TAURINE TRANSPORTER; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

ADAPTATION; ANGIOGENESIS; ARTICLE; BLOOD FLOW; BLOOD VESSEL REACTIVITY; BODY MASS; CATALYSIS; CELL DIFFERENTIATION; CELL GROWTH; COVALENT BOND; DNA MODIFICATION; FETUS DEVELOPMENT; FETUS GROWTH; GAS; HORMONE SYNTHESIS; HUMAN; HYPOXEMIA; IN VITRO STUDY; INTRAUTERINE GROWTH RETARDATION; LARGE FOR GESTATIONAL AGE; MATERNAL DISEASE; METABOLISM; NITRATION; NITRATIVE STRESS; NUTRIENT; OBESITY; OXIDATIVE STRESS; PLACENTA; PLACENTA CIRCULATION; PLACENTA FUNCTION; PLACENTA VILLUS; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; STROMA; SYNCYTIOTROPHOBLAST; TROPHOBLAST; UTERUS BLOOD FLOW;

ANIMALS; FEMALE; HUMANS; MATERNAL-FETAL EXCHANGE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 76749110706     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2009.12.021     Document Type: Article

References (53)

1. Krebs C., Macara L.M., Leiser R., Bowman A.W., Greer I.A., and Kingdom J.C. Intrauterine growth restriction with absent end-diastolic flow velocity in the umbilical artery is associated with maldevelopment of the placental terminal villous tree. Am J Obstet Gynecol 175 6 (1996) 1534-1542
2. Vonnahme K.A., and Ford S.P. Differential expression of the vascular endothelial growth factor-receptor system in the gravid uterus of yorkshire and Meishan pigs. Biol Reprod 71 1 (2004) 163-169
3. + exchanger is reduced in syncytiotrophoblast microvillous plasma membranes isolated from preterm intrauterine growth restriction pregnancies. J Clin Endocrinol Metab 87 12 (2002) 5686-5694
4. McMullen S., Osgerby J.C., Thurston L.M., Gadd T.S., Wood P.J., Wathes D.C., et al. Alterations in placental 11 beta-hydroxysteroid dehydrogenase (11 betaHSD) activities and fetal cortisol:cortisone ratios induced by nutritional restriction prior to conception and at defined stages of gestation in ewes. Reproduction 127 6 (2004) 717-725
5. Myatt L. Placental adaptive responses and fetal programming. J Physiol (2006)
6. Barker D.J. The origins of the developmental origins theory. J Intern Med 261 5 (2007) 412-417
7. Jansson T., Wennergren M., and Powell T.L. Placental glucose transport and GLUT 1 expression in insulin-dependent diabetes. Am J Obstet Gynecol 180 1 Pt 1 (1999) 163-168
8. Jansson T., Ekstrand Y., Wennergren M., and Powell T.L. Placental glucose transport in gestational diabetes mellitus. Am J Obstet Gynecol 184 2 (2001) 111-116
9. Burton G.J., and Caniggia I. Hypoxia: implications for implantation to delivery - a workshop report. Placenta 22 Suppl. A (2001) S63-S65
10. Hung T.H., Skepper J.N., and Burton G.J. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 159 3 (2001) 1031-1043
11. Wang Y., and Walsh S.W. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in pre-eclampsia. Placenta 22 2-3 (2001) 206-212
12. Myatt L., Rosenfield R.B., Eis A.L., Brockman D.E., Greer I., and Lyall F. Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action. Hypertension 28 3 (1996) 488-493
13. Palm M., Axelsson O., Wernroth L., and Basu S. F(2)-isoprostanes, tocopherols and normal pregnancy. Free Radic Res 43 6 (2009) 546-552
14. Morris J.M., Gopaul N.K., Endresen M.J., Knight M., Linton E.A., Dhir S., et al. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 105 11 (1998) 1195-1199
15. Toescu V., Nuttall S.L., Martin U., Kendall M.J., and Dunne F. Oxidative stress and normal pregnancy. Clin Endocrinol (Oxf) 57 5 (2002) 609-613
16. Wisdom S.J., Wilson R., McKillop J.H., and Walker J.J. Antioxidant systems in normal pregnancy and in pregnancy-induced hypertension. Am J Obstet Gynecol 165 6 Pt 1 (1991) 1701-1704
17. Zusterzeel P.L., Rutten H., Roelofs H.M., Peters W.H., and Steegers E.A. Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta 22 2-3 (2001) 213-219
18. Giugliano D., Ceriello A., and Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 19 3 (1996) 257-267
19. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87 1 (2007) 315-424
20. Lyall F., Gibson J.L., Greer I.A., Brockman D.E., Eis A.L., and Myatt L. Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care 21 10 (1998) 1753-1758
21. Madamanchi N.R., Vendrov A., and Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25 1 (2005) 29-38
22. Many A., Westerhausen-Larson A., Kanbour-Shakir A., and Roberts J.M. Xanthine oxidase/dehydrogenase is present in human placenta. Placenta 17 5-6 (1996) 361-365
23. Matsubara S., and Sato I. Enzyme histochemically detectable NAD(P)H oxidase in human placental trophoblasts: normal, preeclamptic, and fetal growth restriction-complicated pregnancy. Histochem Cell Biol 116 1 (2001) 1-7
24. Raijmakers M.T., Peters W.H., Steegers E.A., and Poston L. NAD(P)H oxidase associated superoxide production in human placenta from normotensive and pre-eclamptic women. Placenta 25 Suppl. A (2004) S85-S89
25. Cheng G., Cao Z., Xu X., van Meir E.G., and Lambeth J.D. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269 1-2 (2001) 131-140
26. Griendling K.K. Novel NAD(P)H oxidases in the cardiovascular system. Heart 90 5 (2004) 491-493
27. Cui X.L., Brockman D., Campos B., and Myatt L. Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia. Placenta 27 4-5 (2006) 422-431
28. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 2 (1991) 109-142
29. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A 101 12 (2004) 4003-4008
30. Beckmann J.S., Ye Y.Z., Anderson P.G., Chen J., Accavitti M.A., Tarpey M.M., et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler 375 2 (1994) 81-88
31. Souza J.M., Choi I., Chen Q., Weisse M., Daikhin E., Yudkoff M., et al. Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys 380 2 (2000) 360-366
32. MacMillan-Crow L.A., Crow J.P., and Thompson J.A. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry 37 6 (1998) 1613-1622
33. Zou M.H., Leist M., and Ullrich V. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am J Pathol 154 5 (1999) 1359-1365
34. Szabo C., Zingarelli B., O'Connor M., and Salzman A.L. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A 93 5 (1996) 1753-1758
35. Landino L.M., Crews B.C., Timmons M.D., Morrow J.D., and Marnett L.J. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci U S A 93 26 (1996) 15069-15074
36. Aulak K.S., Koeck T., Crabb J.W., and Stuehr D.J. Dynamics of protein nitration in cells and mitochondria. Am J Physiol Heart Circ Physiol 286 1 (2004) H30-H38
37. Kuo W.N., Kanadia R.N., Shanbhag V.P., and Toro R. Denitration of peroxynitrite-treated proteins by 'protein nitratases' from rat brain and heart. Mol Cell Biochem 201 1-2 (1999) 11-16
38. Low S.Y., Sabetkar M., Bruckdorfer K.R., and Naseem K.M. The role of protein nitration in the inhibition of platelet activation by peroxynitrite. FEBS Lett 511 1-3 (2002) 59-64
39. Koeck T., Fu X., Hazen S.L., Crabb J.W., Stuehr D.J., and Aulak K.S. Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria. J Biol Chem 279 26 (2004) 27257-27262
40. Elfering S.L., Haynes V.L., Traaseth N.J., Ettl A., and Giulivi C. Aspects, mechanism, and biological relevance of mitochondrial protein nitration sustained by mitochondrial nitric oxide synthase. Am J Physiol Heart Circ Physiol 286 1 (2004) H22-H29
41. Souza J.M., Daikhin E., Yudkoff M., Raman C.S., and Ischiropoulos H. Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys 371 2 (1999) 169-178
42. Schopfer F.J., Baker P.R., and Freeman B.A. NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response?. Trends Biochem Sci 28 12 (2003) 646-654
43. Kossenjans W., Eis A., Sahay R., Brockman D., and Myatt L. Role of peroxynitrite in altered fetal-placental vascular reactivity in diabetes or preeclampsia. Am J Physiol Heart Circ Physiol 278 4 (2000) H1311-H1319
44. Mudgett J.S., Ding J., Guh-Siesel L., Chartrain N.A., Yang L., Gopal S., et al. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci U S A 97 19 (2000) 10454-10459
45. Webster R.P., Brockman D., and Myatt L. Nitration of p38 MAPK in the placenta: association of nitration with reduced catalytic activity of p38 MAPK in pre-eclampsia. Mol Hum Reprod 12 11 (2006) 677-685
46. Webster R.P., Macha S., Brockman D., and Myatt L. Peroxynitrite treatment in vitro disables catalytic activity of recombinant p38 MAPK. Proteomics 6 17 (2006) 4838-4844
47. Roberts V.H., Webster R.P., Brockman D.E., Pitzer B.A., and Myatt L. Post-translational modifications of the P2X(4) purinergic receptor subtype in the human placenta are altered in preeclampsia. Placenta 28 4 (2007) 270-277
48. Baeten J.M., Bukusi E.A., and Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health 91 3 (2001) 436-440
49. Rode L., Nilas L., Wojdemann K., and Tabor A. Obesity-related complications in Danish single cephalic term pregnancies. Obstet Gynecol 105 3 (2005) 537-542
50. Boney C.M., Verma A., Tucker R., and Vohr B.R. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 115 3 (2005) e290-e296
51. Dandona P., Aljada A., Chaudhuri A., Mohanty P., and Garg R. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 11 (2005) 1448-1454
52. Greenberg A.S., and Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83 2 (2006) 461S-465S
53. Roberts V.H., Smith J., McLea S.A., Heizer A.B., Richardson J.L., and Myatt L. Effect of increasing maternal body mass index on oxidative and nitrative stress in the human placenta. Placenta 30 2 (2009) 169-175